The present invention relates to a carbonic anhydrase IX targeting compound for the use in the treatment of cancer, wherein the use comprises quantifying CAIX expression as well as the determination of a CAIX score based on the CAIX expression. The present invention relates further to a method for diagnosing, predicting and/or classifying a cancer disease comprising quantifying CAIX expression, and the determination of a CAIX score.
申请公布号
SG11201506635T(A)
申请公布日期
2015.09.29
申请号
SGT11201506635
申请日期
2014.02.21
申请人
WILEX AG
发明人
WILHELM, OLAF;BEVAN, PAUL;FALL, BARBARA;KLÖPFER, PIA;WILHELM, OLAF;BEVAN, PAUL;FALL, BARBARA;KLÖPFER, PIA